Oxygenta Pharmaceutical Ltd Share Price & Stock Analysis

Oxygenta Pharmaceutical Ltd (BSE: 524636) is a Hyderabad, Telangana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹179 Cr, it ranks #2,752 by market cap among the 6,197 Indian listed companies on FinBizNet, and #38 of 63 in Pharmaceuticals. At ₹50.77 (as of 16 Nov 2026), the share price is 29.1% below its 52-week high of ₹71.59 and 18.1% above its 52-week low of ₹43.00. The share price is down 24.0% over one year and down 24.6% over three months.

Key Metrics

Current Price₹50.77
Market Cap₹179 Cr
BSE Code524636
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E RatioNot meaningful (loss)
Return on Equity51.90%
Return on Assets-10.72%
52-Week Range₹43.00 – ₹71.59
1-Year Price Change-24.0%
3-Month Price Change-24.6%
Beta (1Y)0.62
HeadquartersHyderabad, Telangana
Websitewww.oxygentapharma.com

Shareholding and Delivery

Delivery averaged 98.3% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India. It offers active pharmaceuticals ingredients and commercial intermediates. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India.

Products and Services

1. Pharmaceuticals-This segment engages in the manufacture and marketing of bulk drugs and intermediates in India. It produces quinolones, anti-asthmatic, anti-ulcerant, and anti-inflammatory drugs.

Business Segments

1. Manufacturing of Pharmaceutical Products-100%

Oxygenta Pharmaceutical Ltd vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Oxygenta Pharmaceutical Ltd₹179 Crn/m51.90%—-24.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Oxygenta Pharmaceutical Ltd?

Oxygenta Pharmaceutical Ltd is trading at ₹50.77, with a market capitalisation of ₹179 Cr.

Which sector does Oxygenta Pharmaceutical Ltd belong to?

Oxygenta Pharmaceutical Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Oxygenta Pharmaceutical Ltd?

Oxygenta Pharmaceutical Ltd has a return on equity of 51.90%.

What is the stock symbol of Oxygenta Pharmaceutical Ltd?

Oxygenta Pharmaceutical Ltd is listed on the BSE under the scrip code 524636.

How has Oxygenta Pharmaceutical Ltd's share price moved over the past year?

Oxygenta Pharmaceutical Ltd's share price is down 24.0% over one year and down 24.6% over three months. Its 52-week range is ₹43.00 to ₹71.59.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.